Histopathological Study of The Effect of Cisplatin on The Ovaries of Females' Albino Mice
Keywords:
Cisplatin, ovary, chemotherapy, mice, morphologyAbstract
Cisplatin is a chemotherapeutic agent used for treatment of solid tumors and is asserted as an intermediately gonadotoxic agent. The present study was designed to study the cytotoxic effect of cisplatin on the ovaries of females' albino mice. Twenty adult albino females' mice (11 weeks old, with 25gm average weight) were randomly divided into two groups. Group (1) injected i.p. 0.025mg cisplatin\kg B.W. as a single dose, group (2) control. Ten females (five from each group) were dissected after 6 days from injection, while the remaining ten females were dissected after 12 days. Then the cytotoxic effect of cisplatin on both ovarian follicles was evaluated by separately counting each follicle in the histological sections, in addition to study their histopathological changes. The results showed that treatment with cisplatin caused a significant decreased number of ovarian follicles compared with control group and this effect was increased with time after administration. The histopathological study revealed that cisplatin caused damaged in both cortical ovarian follicles and medulla layers. These damages included the detachment of tunica albugina from the ovarian tissues; congestion of blood vessels, pyknosis, shrinkage and deforming of the follicular ova; pyknosis of granulosa cells and their detachment from the basement membrane; disorganization of granulosa cells in addition to disruption of their intracellular contacts with oocytes and destruction of theca cells. In conclusion: treatment with single dose of cisplatin caused damage and significant decrease in number of ovarian follicles which may result in females' infertility.
References
Arbaje Y. M., Bittner G., Yingling J. M., Storer B. and Schiller J. H. (1993): Antiproliferative effects of interferons -alpha and -beta in combination with 5-fluorouracil, cisplatin, and cis- and trans-retinoic acid in three human lung carcinoma cell lines. J Interferon Res., 13(1): 25-32.
Bancroft, J. D.; Stevens, A. and Turner, D. R. (1999): In tissue processing microtomy and paraffin sections. In theory and practice of histological techniques. By Bancroft, J. D.; Steven, A. and turner, D. R. 4th ed. Churchil Livingstone. London.
ChirinoY. I. and Pedraza-Chaverri J., (2009): Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Experimental and Toxicologic Pathology, 61(3): 223–242.
El-Sayyad H. I., Ismail M. F., Shalaby F. M., Abou-El-Magd R. F., Gaur R. L., Fernando A., Raj M. H. G. and Ouhtit A. (2009): Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats. Int J Biol Sci., 5(5): 466-473.
Florea A-M. and Büsselberg D. (2011): Cisplatin as an anti-tumor drug: Cellular mechanisms of aqctivity, drug resistance and induced side effects.Cancers, 3, 1351-1371
Gerschenson M. and Paik C. Y. (2001): Cisplatin exposure induces mitochondrial toxicity in pregnant rats and their fetuses. Reprod Toxicol, 15: 525–531.
Gustavo N., Kalil N., Patrick W. and McGuire (2002): Chemotherapy for advanced epithelial ovarian carcinoma. ÊBest Practice and Research Clinical Obstetrics and Gynaecology, 16:553-557.
Hanigan M. H. and Devarajan P. (2003): Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther., 1: 47-61.
Himelstein-Braw R., Byskov A. G., Peters H. and Faber M. (1976) Follicular atresia in the infant human ovary. J Reprod Fertil, 46: 55-59.
Jemal A., Murray T., Samuels A., Ghafoor A., Ward E. and Thun M. J. (2003): Cancer statistics, 2003. Ca-A Cancer Journal for Clinicians, 53(1):5-26.
Loehrer P.J. and Einhorn L.H. (1984): Cisplatin. Ann. Intern. Med., 100: 704-713.
Malarczyk E., Kandefer-Szerszeri M., and Jarosz-Wilkolazka A. (2003): The influence of very low doses of cisplatin on tumor cell proliferation in vitro and on some hematological and enzymatic parameters of healthy rats. Nonlinearity in Biology, Toxicology, and Medicine, 1(1): 123-137.
Meirow D, Lewis H, Nugent D. and Epstein M. (1999): Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum Reprod., 14:1903-1907.
Nakagawa S., Nakamura N., Fujioka M. and Mori C. (1997): Spermatogenic ell apoptosis induced by mitomycin C in the mouse testis Toxicology and Applied Pharmacology, 147: 204-213.
Oktay K., Buyuk E., Libertella N., Akar M. and Rosenwaks Z. (2005): Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. Journal of Clinical Oncology, 23(19): 4347-4353.
Park H. R., Ju E. J., Jo S. K., Jumg U., Kim A. H. and Yee S. T, (2009): Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor- bearing mice. BMC cancer, 9:85.
Rabik C. A. and Dolan M. E. (2007): Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev., 33 (1): 9-23.
Sommezer M. and Oktay K. (2004): Fertility reservation in female patients. Human Reproduction Update,10(3): 251–266.
Tangir J., Zelterman D., Ma W. and Schwartz P. E.(2003): Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstetrics & Gynecology, 101(2): 251257.
Türkyılmaz C., Özçelik B., Özgün M.T., Atakul T., Batukan C.; Serin İ. S. and Özdamar S. (2008): Effects of paclitaxel and cisplatin on ovarian rserves in rats. Erciyes Týp Dergisi (Erciyes Medical Journal), 30(1):24-29.
Vaisheva F., Delbes G., Hales B. F. and Robaire B. (2007): Effect of the chemotherapeutic agents for non-Hodgkin lymphoma, cyclophosphamide, doxorubicin, Vincristine, and Prednisone (CHOP) on the male rat reproductive system and progeny outcome. Journal of Androl., 28(4): 578-587.
Waheed I. N. and Esa H.Y. (2012): The effect of different doses of Mitomycin C on the male albino mice reproductive system. Proceeding of "The Third International Conference for Medical Sciences 24- 26 October 2012), Hawler Medical University and Kurdistan Board for Medical Specialties, Erbil, Iraq. 131-142
Weijl N. I., Wipkink-Bakker A., Lentjes E. G. W. M., Berger H. M., Cleton F. J., and Osanto (1998): Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Annals of Oncology, 9(12): 1331-1337.
Yeh J., Kim B S. and Peresie J. (2011): Reproductive toxic effects of cisplatin and its modulation by the antioxidant sodium 2-mercaptoethanesulfonate (Mesna) in female rats. Reproductive Biology Insights, 5: 17-26
Yucebilgin M. S., Terek M. C. and Ozsaran A. (2004): Effect of chemotherapy on primordial follicular reserve of rat: an animal model of premature ovarian failure and infertility. Australian and New Zealand Journal of Obstetrics and Gynaecology, 44(1): 6-9.
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-SA 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work, with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online.
